Gerresheimer performance levels simplify choice of optimum solution
Three performance levels for injection vials, syringes, ampoules and cartridges Clear and consistent structure for s…
Three performance levels for injection vials, syringes, ampoules and cartridges Clear and consistent structure for s…
Interim clinical data update on ACTengine® IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objec…
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic,…
REVeRT, a dual vector approach based on mRNA trans-splicing, enables delivery of genes larger than the usual AAV packagi…
At its Capital Markets Day, Lonza outlined its Mid-Term Guidance for 2024 to 2028, including: 11–13% sales growth, 3…
. - Suitable for cryogenic storage - High break resistance - Prevention of delamination Gerresheimer, innovative syste…
Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules Comp…
In H1 2023, Lonza delivered CHF 3.1 billion sales and 5.6% CER1 sales growth, corresponding to around 10% CER underlying…